SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Cederberg C) "

Sökning: WFRF:(Cederberg C)

  • Resultat 1-10 av 36
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Zillikens, M. C., et al. (författare)
  • Large meta-analysis of genome-wide association studies identifies five loci for lean body mass
  • 2017
  • Ingår i: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 8:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Lean body mass, consisting mostly of skeletal muscle, is important for healthy aging. We performed a genome-wide association study for whole body (20 cohorts of European ancestry with n = 38,292) and appendicular (arms and legs) lean body mass (n = 28,330) measured using dual energy X-ray absorptiometry or bioelectrical impedance analysis, adjusted for sex, age, height, and fat mass. Twenty-one single-nucleotide polymorphisms were significantly associated with lean body mass either genome wide (p < 5 x 10(-8)) or suggestively genome wide (p < 2.3 x 10(-6)). Replication in 63,475 (47,227 of European ancestry) individuals from 33 cohorts for whole body lean body mass and in 45,090 (42,360 of European ancestry) subjects from 25 cohorts for appendicular lean body mass was successful for five single-nucleotide polymorphisms in/ near HSD17B11, VCAN, ADAMTSL3, IRS1, and FTO for total lean body mass and for three single-nucleotide polymorphisms in/ near VCAN, ADAMTSL3, and IRS1 for appendicular lean body mass. Our findings provide new insight into the genetics of lean body mass.
  •  
2.
  • Bar, N., et al. (författare)
  • A reference map of potential determinants for the human serum metabolome
  • 2020
  • Ingår i: Nature. - : Nature Research. - 0028-0836 .- 1476-4687. ; 588:7836, s. 135-140
  • Tidskriftsartikel (refereegranskat)abstract
    • The serum metabolome contains a plethora of biomarkers and causative agents of various diseases, some of which are endogenously produced and some that have been taken up from the environment1. The origins of specific compounds are known, including metabolites that are highly heritable2,3, or those that are influenced by the gut microbiome4, by lifestyle choices such as smoking5, or by diet6. However, the key determinants of most metabolites are still poorly understood. Here we measured the levels of 1,251 metabolites in serum samples from a unique and deeply phenotyped healthy human cohort of 491 individuals. We applied machine-learning algorithms to predict metabolite levels in held-out individuals on the basis of host genetics, gut microbiome, clinical parameters, diet, lifestyle and anthropometric measurements, and obtained statistically significant predictions for more than 76% of the profiled metabolites. Diet and microbiome had the strongest predictive power, and each explained hundreds of metabolites—in some cases, explaining more than 50% of the observed variance. We further validated microbiome-related predictions by showing a high replication rate in two geographically independent cohorts7,8 that were not available to us when we trained the algorithms. We used feature attribution analysis9 to reveal specific dietary and bacterial interactions. We further demonstrate that some of these interactions might be causal, as some metabolites that we predicted to be positively associated with bread were found to increase after a randomized clinical trial of bread intervention. Overall, our results reveal potential determinants of more than 800 metabolites, paving the way towards a mechanistic understanding of alterations in metabolites under different conditions and to designing interventions for manipulating the levels of circulating metabolites. 
  •  
3.
  • Bergez, J-E, et al. (författare)
  • Integrating agri-environmental indicators, ecosystem services assessment, life cycle assessment and yield gap analysis to assess the environmental sustainability of agriculture.
  • 2022
  • Ingår i: Ecological Indicators. - : Elsevier BV. - 1470-160X. ; 141
  • Tidskriftsartikel (refereegranskat)abstract
    • Agriculture’s primary function is the production of food, feed, fibre and fuel for the fast-growing world population. However, it also affects human health and ecosystem integrity. Policymakers make policies in order to avoid harmful impacts. How to assess such policies is a challenge. In this paper, we propose a conceptual framework to help evaluate the impacts of agricultural policies on the environment. Our framework represents the global system as four subsystems and their interactions. These four components are the cells of a 2 by 2 matrix [Agriculture, Rest of the word]; [Socio-eco system, Ecological system]. We then developed a set of indicators for environmental issues and positioned these issues in the framework. To assess these issues, we used four well-known existing approaches: Life Cycle Assessment, Ecosystem Services Analysis, Yield Gap Analysis and Agro-Environmental Indicators. Using these four approaches together provided a more holistic view of the impacts of a given policy on the system. We then applied our framework on existing cover crop policies using an extensive literature survey and analysing the different environmental issues mobilised by the four assessment approaches. This demonstration case shows that our framework may be of help for a full systemic assessment. Despite their differences (aims, scales, standardization, data requirements, etc.), it is possible and profitable to use the four approaches together. This is a significant step forward, though more work is needed to produce a genuinely operational tool.
  •  
4.
  •  
5.
  • Andersen, Gregers Stig Tig, et al. (författare)
  • The DEXLIFE study methods : identifying novel candidate biomarkers that predict progression to type 2 diabetes in high risk individuals
  • 2014
  • Ingår i: Diabetes Research and Clinical Practice. - : Elsevier. - 0168-8227 .- 1872-8227. ; 106:2, s. 383-389
  • Tidskriftsartikel (refereegranskat)abstract
    • The incidence of type 2 diabetes (T2D) is rapidly increasing worldwide and T2D is likely to affect 592 million people in 2035 if the current rate of progression is continued. Today, patients are diagnosed with T2D based on elevated blood glucose, either directly or indirectly (HbA1c). However, the information on disease progression is limited. Therefore, there is a need to identify novel early markers of glucose intolerance that reflect the underlying biology and the overall physiological, metabolic and clinical characteristics of progression towards diabetes. In the DEXLIFE study, several clinical cohorts provide the basis for a series of clinical, physiological and mechanistic investigations in combination with a range of--omic technologies to construct a detailed metabolic profile of high-risk individuals across multiple cohorts. In addition, an exercise and dietary intervention study is conducted, that will assess the impact on both plasma biomarkers and specific functional tissue-based markers. The DEXLIFE study will provide novel diagnostic and predictive biomarkers which may not only effectively detect the progression towards diabetes in high risk individuals but also predict responsiveness to lifestyle interventions known to be effective in the prevention of diabetes.
  •  
6.
  • Arlien-Soborg, Mai C., et al. (författare)
  • Acromegaly management in the Nordic countries: A Delphi consensus survey
  • 2024
  • Ingår i: Clinical Endocrinology. - : WILEY. - 0300-0664 .- 1365-2265.
  • Tidskriftsartikel (refereegranskat)abstract
    • ObjectiveAcromegaly is associated with increased morbidity and mortality if left untreated. The therapeutic options include surgery, medical treatment, and radiotherapy. Several guidelines and recommendations on treatment algorithms and follow-up exist. However, not all recommendations are strictly evidence-based. To evaluate consensus on the treatment and follow-up of patients with acromegaly in the Nordic countries.MethodsA Delphi process was used to map the landscape of acromegaly management in Denmark, Sweden, Norway, Finland, and Iceland. An expert panel developed 37 statements on the treatment and follow-up of patients with acromegaly. Dedicated endocrinologists (n = 47) from the Nordic countries were invited to rate their extent of agreement with the statements, using a Likert-type scale (1-7). Consensus was defined as >= 80% of panelists rating their agreement as >= 5 or <= 3 on the Likert-type scale.ResultsConsensus was reached in 41% (15/37) of the statements. Panelists agreed that pituitary surgery remains first line treatment. There was general agreement to recommend first-generation somatostatin analog (SSA) treatment after failed surgery and to consider repeat surgery. In addition, there was agreement to recommend combination therapy with first-generation SSA and pegvisomant as second- or third-line treatment. In more than 50% of the statements, consensus was not achieved. Considerable disagreement existed regarding pegvisomant monotherapy, and treatment with pasireotide and dopamine agonists.ConclusionThis consensus exploration study on the management of patients with acromegaly in the Nordic countries revealed a relatively large degree of disagreement among experts, which mirrors the complexity of the disease and the shortage of evidence-based data.
  •  
7.
  • Arlien-Søborg, Mai C., et al. (författare)
  • Acromegaly management in the nordic countries : a Delphi consensus survey
  • 2024
  • Ingår i: Clinical Endocrinology. - : John Wiley & Sons. - 0300-0664 .- 1365-2265.
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective: Acromegaly is associated with increased morbidity and mortality if left untreated. The therapeutic options include surgery, medical treatment, and radiotherapy. Several guidelines and recommendations on treatment algorithms and follow-up exist. However, not all recommendations are strictly evidence-based. To evaluate consensus on the treatment and follow-up of patients with acromegaly in the Nordic countries.Methods: A Delphi process was used to map the landscape of acromegaly management in Denmark, Sweden, Norway, Finland, and Iceland. An expert panel developed 37 statements on the treatment and follow-up of patients with acromegaly. Dedicated endocrinologists (n = 47) from the Nordic countries were invited to rate their extent of agreement with the statements, using a Likert-type scale (1−7). Consensus was defined as ≥80% of panelists rating their agreement as ≥5 or ≤3 on the Likert-type scale.Results: Consensus was reached in 41% (15/37) of the statements. Panelists agreed that pituitary surgery remains first line treatment. There was general agreement to recommend first-generation somatostatin analog (SSA) treatment after failed surgery and to consider repeat surgery. In addition, there was agreement to recommend combination therapy with first-generation SSA and pegvisomant as second- or third-line treatment. In more than 50% of the statements, consensus was not achieved. Considerable disagreement existed regarding pegvisomant monotherapy, and treatment with pasireotide and dopamine agonists.Conclusion: This consensus exploration study on the management of patients with acromegaly in the Nordic countries revealed a relatively large degree of disagreement among experts, which mirrors the complexity of the disease and the shortage of evidence-based data.
  •  
8.
  • Büchert, A., et al. (författare)
  • Dioxin contamination in food : Bayreuth, Germany, from September 28 to October 1, 2000
  • 2001
  • Ingår i: Environmental Science and Pollution Research. - : Ecomed Publishers. - 0944-1344 .- 1614-7499. ; 8:2, s. 84-88
  • Tidskriftsartikel (refereegranskat)abstract
    • Dioxin and PCB monitoring programs for food and feeding stuff in most countries of the world, including many European Countries are currently inadequate. Better control of food production lines and food processing procedures is needed to minimize entry of dioxin to the food chain and will help to avoid dioxin contamination accidents. This would also improve the ability to trace back a possible contamination to its source. European guidelines for monitoring programs should be established to ensure comparable and meaningful results. These guidelines should define the minimum requirements for the design of monitoring programs, analytical methods, and quality assurance.Though data from Northern Europe shows that the general population exposure to dioxin and PCB has decreased during the last ten years these compounds continue to be a risk of accidental contamination of the food chain. The most prominent recent example is the Belgian dioxin contamination of feeding stuff in 1999. The Belgian dioxin contamination was not detected due to dioxin monitoring programs but by their direct biological effects seen in animals. Four other cases of dioxin contamination have been detected in Europe since 1997 due to local monitoring programs. One of them (citrus pulp pellets 1998) was in a much larger scale than the Belgian dioxin contamination.The general population's exposure to dioxins and PCBs is still in the same range (1-4 pg WHO-TEQ/kg body weight and day) as the recently revised WHO tolerable daily intake (TDI). There is concern that short-term high level exposure to dioxins, furans, and PCB may cause biological effects on the human fetal development and further research is required.Further actions to control sources building on considerable advances already made in many countries may need to be supplemented by measures to prevent direct contamination of feeding stuff or food to reduce general population exposure further.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 36
Typ av publikation
rapport (20)
tidskriftsartikel (14)
bok (1)
annan publikation (1)
Typ av innehåll
övrigt vetenskapligt/konstnärligt (19)
refereegranskat (17)
Författare/redaktör
Cederberg, Henna (3)
Karlsson, Magnus (2)
Schwenk, Jochen M. (2)
Vandenput, Liesbeth, ... (2)
Lorentzon, Mattias, ... (2)
Walker, M (2)
visa fler...
Lind, Lars (2)
Feldt-Rasmussen, Ull ... (2)
Carlsson, P (2)
Larsson, C (2)
Matikainen, Niina (2)
Ohlsson, Claes, 1965 (2)
Olsson, Tommy (2)
Laakso, Markku (2)
Eriksson, Joel (2)
Grallert, H. (2)
Berinder, Katarina (2)
Burman, Pia (2)
Dahlqvist, Per (2)
Ekman, Bertil (2)
Melhus, Håkan (2)
Mellström, Dan, 1945 (2)
Laakso, M. (2)
Lagercrantz, S (2)
Johannsson, Gudmundu ... (2)
Stochholm, Kirstine (2)
Hong, Mun-Gwan (2)
Walker, Mark (2)
Petersson, Maria (2)
Byberg, Liisa (2)
Ljunggren, Östen (2)
Jansson, John-Olov, ... (2)
Spector, T. D. (2)
Dal, Jakob (2)
Heck, Ansgar (2)
Husted, Eigil (2)
Feltoft, Claus Larse ... (2)
Andreassen, Mikkel (2)
Klose, Marianne Chri ... (2)
Nielsen, Torben Leo (2)
Andersen, Marianne S ... (2)
Christensen, Louise ... (2)
Krogh, Jesper (2)
Jarlov, Anne (2)
Bollerslev, Jens (2)
Nermoen, Ingrid (2)
Oksnes, Marianne (2)
Hoybye, Charlotte (2)
Akerman, Anna-karin (2)
Wahlberg, Jeanette (2)
visa färre...
Lärosäte
RISE (20)
Karolinska Institutet (4)
Linköpings universitet (3)
Lunds universitet (3)
Göteborgs universitet (2)
Umeå universitet (2)
visa fler...
Kungliga Tekniska Högskolan (2)
Uppsala universitet (2)
Örebro universitet (2)
Mittuniversitetet (1)
Chalmers tekniska högskola (1)
Linnéuniversitetet (1)
visa färre...
Språk
Engelska (27)
Svenska (9)
Forskningsämne (UKÄ/SCB)
Lantbruksvetenskap (22)
Medicin och hälsovetenskap (7)
Naturvetenskap (3)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy